↓ Skip to main content

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE…

Overview of attention for article published in Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, November 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs
1 blog
twitter
5 X users

Citations

dimensions_citation
114 Dimensions

Readers on

mendeley
94 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial
Published in
Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, November 2014
DOI 10.1161/jaha.114.001363
Pubmed ID
Authors

David C. Wheeler, Gerard M. London, Patrick S. Parfrey, Geoffrey A. Block, Ricardo Correa‐Rotter, Bastian Dehmel, Tilman B. Drüeke, Jürgen Floege, Yumi Kubo, Kenneth W. Mahaffey, William G. Goodman, Sharon M. Moe, Marie‐Louise Trotman, Safa Abdalla, Glenn M. Chertow, Charles A. Herzog, the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events Trial Investigators

Abstract

Premature cardiovascular disease limits the duration and quality of life on long-term hemodialysis. The objective of this study was to define the frequency of fatal and nonfatal cardiovascular events attributable to atherosclerotic and nonatherosclerotic mechanisms, risk factors for these events, and the effects of cinacalcet, using adjudicated data collected during the EValuation of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 1%
Australia 1 1%
Unknown 92 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 14%
Student > Ph. D. Student 11 12%
Student > Postgraduate 10 11%
Student > Bachelor 10 11%
Other 9 10%
Other 20 21%
Unknown 21 22%
Readers by discipline Count As %
Medicine and Dentistry 46 49%
Nursing and Health Professions 8 9%
Biochemistry, Genetics and Molecular Biology 3 3%
Psychology 2 2%
Agricultural and Biological Sciences 1 1%
Other 8 9%
Unknown 26 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2022.
All research outputs
#3,537,068
of 25,394,764 outputs
Outputs from Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease
#2,831
of 8,254 outputs
Outputs of similar age
#47,366
of 368,147 outputs
Outputs of similar age from Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease
#21
of 70 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,254 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.7. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,147 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.